Cryptic activity of atypical hemolytic uremic syndrome and eculizumab treatment

Pediatrics

Volumn 133, Issue 6, 2014, Pages

  Belingheri, Mirco ^a   Possenti, Ilaria ^a   Tel, Francesca ^a   Paglialonga, Fabio ^a   Testa, Sara ^a   Salardi, Stefania ^a   Ardissino, Gianluigi ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

End stage renal disease; Hemolitic uremic syndrome; Proteinuria

Indexed keywords

AMLODIPINE; ATENOLOL; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; CREATININE; ECULIZUMAB; FRESH FROZEN PLASMA; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; MINOXIDIL; RAMIPRIL;

ARTICLE; BLOOD PRESSURE REGULATION; BODY WEIGHT; CASE REPORT; CHILD; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENE MUTATION; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; INFANT; KIDNEY FUNCTION; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEINURIA; RELAPSE; REMISSION; THROMBOCYTE COUNT; URINARY EXCRETION; URTICARIA;

END-STAGE RENAL DISEASE; HEMOLITIC UREMIC SYNDROME; PROTEINURIA;

ANTIBODIES, MONOCLONAL, HUMANIZED; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; COMPLEMENT ACTIVATION; COMPLEMENT FACTOR H; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; HAPTOGLOBINS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; KIDNEY FUNCTION TESTS; L-LACTATE DEHYDROGENASE; LONGITUDINAL STUDIES; MALE; PLASMA; PLASMAPHERESIS; PLATELET COUNT; PROTEINURIA; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE;

EID: 84901839650     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-2921     Document Type: Article

References (8)

1. Kavanagh D, Goodship T. Genetics and complement in atypical HUS. Pediatr Nephrol. 2010;25(12):2431-2442
2. Fremeaux-Bacchi V, Fakhouri F, Garnier A, et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013;8(4):554-562
3. Loirat C, Fremeaux-Bacchi V. Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transplant. 2008;12(6):619-629
4. Legendre CM, Licht C, Muus P, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013;368(23):2169-2181
5. Zuber J, Le Quintrec M, Sberro-Soussan R, Loirat C, Frémeaux- Bacchi V, Legendre C. New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol. 2011;7(1):23-35
6. Fakhouri F, Frémeaux-Bacchi V, Loirat C. Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy [published online ahead of print]. Eur J Intern Med. 2013;24(6):492-495
7. Sallée M, Ismail K, Fakhouri F, et al. Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome. BMC Nephrol. 2013;14(3):1-6
8. De Serres SA, Isenring P. Athrombocytopenic thrombotic microangiopathy, a condition that could be overlooked based on current diagnostic criteria. Nephrol Dial Transplant. 2009;24(3):1048-1050